KLHL24 and generalized dominant dystrophic epidermolysis bullosa: Patients with moderate risk include those with a diagnosis of severe EBS, DDEB, and localized RDEB, while low risk has been established for patients with localized and intermediate EBS due to keratin and KLHL24 mutations.